RAPT Therapeutics (RAPT) Payables: 2020-2024
Historic Payables for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $1.4 million.
- Therapeutics' Payables fell 73.95% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $16.0 million, marking a year-over-year decrease of 20.94%. This contributed to the annual value of $5.2 million for FY2023, which is 53.82% up from last year.
- As of Q3 2024, Therapeutics' Payables stood at $1.4 million, which was down 49.19% from $2.7 million recorded in Q2 2024.
- Therapeutics' Payables' 5-year high stood at $8.9 million during Q1 2023, with a 5-year trough of $1.4 million in Q3 2024.
- For the 3-year period, Therapeutics' Payables averaged around $4.2 million, with its median value being $4.0 million (2022).
- Its Payables has fluctuated over the past 5 years, first spiked by 361.83% in 2023, then crashed by 73.95% in 2024.
- Over the past 5 years, Therapeutics' Payables (Quarterly) stood at $2.4 million in 2020, then dropped by 16.11% to $2.0 million in 2021, then spiked by 68.33% to $3.4 million in 2022, then soared by 53.82% to $5.2 million in 2023, then slumped by 73.95% to $1.4 million in 2024.
- Its Payables was $1.4 million in Q3 2024, compared to $2.7 million in Q2 2024 and $6.8 million in Q1 2024.